MCRB SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Seres Therapeutics, Inc...
November 18 2016 - 10:03AM
Business Wire
The Law Offices of Vincent Wong announce that a class action
lawsuit has been commenced in the USDC for the District of
Massachusetts on behalf of investors who purchased Seres
Therapeutics, Inc. (NASDAQ: MCRB) securities between June 25, 2015
and July 29, 2016.
Click here to learn about the case:
http://www.wongesq.com/pslra/seres-therapeutics-inc. There
is no cost or obligation to you.
According to the complaint, throughout the Class Period, Seres
Therapeutics made materially false and misleading positive
statements about the potential and efficacy of its lead drug
product candidate SER-109. In particular, it is alleged that Seres
touted the drug, calling it one among a “novel class of biological
drugs” and a potential “first-in-field drug” despite knowledge that
the Phase 2 clinical trial of SER-109 would fail to achieve its
primary endpoint as compared to placebo.
On July 29, 2016, the Company issued a press release announcing
that the Phase 2 clinical trial of SER-109 did not achieve its
primary endpoint. In an earnings call, President and CEO Roger J.
Pomerantz also revealed that certain undisclosed modifications had
been made to the formulation of SER-109 prior to the trial.
Following this news, shares of Seres Therapeutics fell from a close
of $35.77 on July 28, 2016, to a close of just $9.73 on August 1,
2016.
If you suffered a loss in Seres Therapeutics you have until
November 28, 2016 to request that
the Court appoint you as lead plaintiff. Your ability to share in
any recovery doesn’t require that you serve as a lead plaintiff. To
obtain additional information, contact Vincent Wong, Esq. either
via email vw@wongesq.com, by telephone at 212.425.1140, or visit
http://www.wongesq.com/pslra/seres-therapeutics-inc.
Vincent Wong, Esq. is an experienced attorney that has
represented investors in securities litigations involving financial
fraud and violations of shareholder rights. Attorney advertising.
Prior results do not guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161118005499/en/
The Law Offices of Vincent WongVincent Wong, Esq.,
212-425-1140Fax: 866-699-3880vw@wongesq.com
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Apr 2024 to May 2024
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From May 2023 to May 2024